Skip to main content
. 2022 May 30;11(11):3079. doi: 10.3390/jcm11113079

Figure 4.

Figure 4

(a) A 43-year-old patient with multifocal invasive-ductal carcinoma (pT1c pN1mi M0) of the right breast. (b) Six months after a nipple sparing mastectomy through a lateral hemi-areolar access with vertical extension and prepectoral expander placement (Motiva Flora® XMF-58 440 cc) and ADM (SurgiMend® PRS meshed, Integra LifeSciences, Princeton NJ, USA) use. (c) One year after expander exchange for a definitive implant (Motiva Ergonomix® ERSD 300 cc) and autologous fat grafting to the mastectomy flap (140 cc) and mastopexy of the left breast (“auto-augmentation”).